PMID- 32392207 OWN - NLM STAT- MEDLINE DCOM- 20200728 LR - 20200728 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 15 IP - 5 DP - 2020 TI - The qualitative assessment of optical coherence tomography and the central retinal sensitivity in patients with retinitis pigmentosa. PG - e0232700 LID - 10.1371/journal.pone.0232700 [doi] LID - e0232700 AB - PURPOSE: To analyze the relationships between qualitative and quantitative parameters of spectral-domain optical coherence tomography (SD-OCT) and the central retinal sensitivity in patients with retinitis pigmentosa (RP). MATERIALS AND METHODS: Ninety-three eyes of 93 patients were finally enrolled, with a median age (quartile) of 58 (24.5) years. We assessed the patients using SD-OCT and the 10-2 program of a Humphry Field Analyzer (HFA). As a qualitative parameter, two graders independently classified the patients' SD-OCT images into five severity grades (grades 1-5) based on the severity of damage to the photoreceptor inner and outer segments (IS/OS) layer. As quantitative parameters, we measured the IS-ellipsoid zone (IS-EZ) width, IS/OS thickness, outer nuclear layer (ONL) thickness, central macular thickness (CMT, 1 and 3 mm) and macular cube (6 x 6 mm) volume and thickness. The central retinal sensitivity was defined by the best-corrected visual acuity (BCVA; logMAR), average sensitivities of the central 4 (foveal sensitivity [FS]) and 12 (macular sensitivity [MS]) points of the HFA 10-2 program and the mean deviation (MD) of the 10-2 program. Spearman's correlation was used to assess the association between both qualitative and quantitative parameters and variables of the central retinal sensitivity. In addition, we performed a multiple regression analysis using these parameters to identify the parameters most strongly influencing the central retinal sensitivity. RESULTS: The IS/OS severity grade was significantly correlated with the BCVA (rho = 0.741, P < 0.001), FS (rho = -0.844, P < 0.001), MS (rho = -0.820, P < 0.001) and MD (rho = -0.681, P < 0.001) and showed stronger correlations to them than any other quantitative parameters including the IS-EZ width, IS/OS thickness, ONL thickness, CMTs and macular cube volume/thickness. Furthermore, a step-wise multiple regression analysis indicated that the IS/OS severity grade was more strongly associated with the BCVA (beta = 0.659, P < 0.001), FS (beta = -0.820, P < 0.001), MS (beta = -0.820, P < 0.001) and MD (beta = -0.674, P < 0.001) than any other quantitative parameters. The intraclass correlation coefficient between two graders indicated substantial correlation (kappa = 0.70). DISCUSSION: The qualitative grading of OCT based on the severity of the IS/OS layer was simple and strongly correlated with the central retinal sensitivity in patients with RP. It may be useful to assess the central visual function in patients with RP, although there is some variation in severity within the same severity grade. FAU - Hara, Aiko AU - Hara A AD - Department of Ophthalmology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. FAU - Nakazawa, Mitsuru AU - Nakazawa M AUID- ORCID: 0000-0001-6095-5712 AD - Department of Ophthalmology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. FAU - Saito, Masaaki AU - Saito M AD - Department of Ophthalmology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. FAU - Suzuki, Yukihiko AU - Suzuki Y AD - Department of Ophthalmology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. LA - eng PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20200511 PL - United States TA - PLoS One JT - PloS one JID - 101285081 SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Child MH - Female MH - Fundus Oculi MH - Humans MH - Male MH - Middle Aged MH - Regression Analysis MH - Retina/*diagnostic imaging/pathology/*physiopathology MH - Retinitis Pigmentosa/*diagnostic imaging/*physiopathology MH - *Tomography, Optical Coherence MH - Young Adult PMC - PMC7213731 COIS- Mitsuru Nakazawa received research funds from Alcon (Tokyo, Japan), Novartis (Tokyo, Japan), Santen (Osaka, Japan), AMO (Tokyo, Japan), HOYA (Tokyo, Japan) and Pfizer (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. EDAT- 2020/05/12 06:00 MHDA- 2020/07/29 06:00 PMCR- 2020/05/11 CRDT- 2020/05/12 06:00 PHST- 2020/02/09 00:00 [received] PHST- 2020/04/19 00:00 [accepted] PHST- 2020/05/12 06:00 [entrez] PHST- 2020/05/12 06:00 [pubmed] PHST- 2020/07/29 06:00 [medline] PHST- 2020/05/11 00:00 [pmc-release] AID - PONE-D-20-03802 [pii] AID - 10.1371/journal.pone.0232700 [doi] PST - epublish SO - PLoS One. 2020 May 11;15(5):e0232700. doi: 10.1371/journal.pone.0232700. eCollection 2020.